Inventor · disambiguated record
George Harb
Also filed as: HARB GEORGE
18 granted patents·19 pending applications·45 citations·filing 2020–2025
93Inventor score
Top patents by PatentIndex Score
37 records- 0196US11525120B2Stem cell derived islet differentiationVERTEX PHARMA·Filed 2021·Granted Dec 13, 2022·9 cites·26 claims
- 0296US11466256B2Stem cell derived islet differentiationVERTEX PHARMA·Filed 2021·Granted Oct 11, 2022·11 cites·30 claims
- 0395US11913029B2Platforms and systems for automated cell cultureCELLINO BIOTECH INC·Filed 2022·Granted Feb 27, 2024·4 cites·22 claims
- 0495US11866735B2Platforms and systems for automated cell cultureCELLINO BIOTECH INC·Filed 2022·Granted Jan 9, 2024·4 cites·25 claims
- 0594US12049645B2Differentiation of pancreatic endocrine cellsVERTEX PHARMA·Filed 2021·Granted Jul 30, 2024·3 cites·33 claims
- 0694US11999971B2Stem cell derived islet differentiationVERTEX PHARMA·Filed 2022·Granted Jun 4, 2024·2 cites·20 claims
- 0793US12006516B2Differentiation of pancreatic endocrine cellsVERTEX PHARMA·Filed 2023·Granted Jun 11, 2024·3 cites·30 claims
- 0893US11931737B2Platforms and systems for automated cell cultureCELLINO BIOTECH INC·Filed 2022·Granted Mar 19, 2024·4 cites·30 claims
- 0993US11680247B2Platforms and systems for automated cell cultureCELLINO BIOTECH INC·Filed 2022·Granted Jun 20, 2023·2 cites·23 claims
- 1091US11708563B2Platforms and systems for automated cell cultureCELLINO BIOTECH INC·Filed 2022·Granted Jul 25, 2023·1 cites·34 claims
- 1190US2025075189A1Platforms and systems for automated cell cultureCELLINO BIOTECH INC·Filed 2024·Application pending·0 cites
- 1288US12385013B2Differentiation of pancreatic endocrine cellsVERTEX PHARMA·Filed 2024·Granted Aug 12, 2025·0 cites·29 claims
- 1388US12371665B2Differentiation of pancreatic endocrine cellsVERTEX PHARMA·Filed 2024·Granted Jul 29, 2025·0 cites·29 claims
- 1487US2024191204A1Platforms and systems for automated cell cultureCELLINO BIOTECH INC·Filed 2023·Application pending·0 cites
- 1586US12173327B2Platforms and systems for automated cell cultureCELLINO BIOTECH INC·Filed 2023·Granted Dec 24, 2024·0 cites·30 claims
- 1686US11992506B2Stem cell derived pancreatic islet differentiationVERTEX PHARMA·Filed 2022·Granted May 28, 2024·2 cites·30 claims
- 1786US2025122478A1Differentiation of pancreatic endocrine cellsVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 1885US12195765B2Platforms and systems for automated cell cultureCELLINO BIOTECH INC·Filed 2023·Granted Jan 14, 2025·0 cites·28 claims
- 1985US2023265394A1Platforms and systems for automated cell cultureCELLINO BIOTECH INC·Filed 2023·Application pending·0 cites
- 2085US2024240153A1Re-aggregation of stem cell-derived pancreatic beta cellsVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 2185US2024117319A1Re-aggregation of stem cell-derived pancreatic beta cellsVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 2284US2025236844A1Stem cell derived islet differentiationVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 2383US12173324B2Differentiation of pancreatic endocrine cellsVERTEX PHARMA·Filed 2022·Granted Dec 24, 2024·0 cites·21 claims
- 2482US2025223565A1Methods of enhancing stem cell differentiation into beta cellsVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 2576US12472496B2Platforms and systems for automated cell cultureCELLINO BIOTECH INC·Filed 2023·Granted Nov 18, 2025·0 cites·26 claims
- 2674US12215355B2Stem cell derived islet differentiationVERTEX PHARMA·Filed 2021·Granted Feb 4, 2025·0 cites·20 claims
- 2773US2023146780A1Methods of enhancing stem cell differentiation into beta cellsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 2873US2023137854A1Methods of enhancing stem cell differentiation into beta cellsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 2970US2024382532A1Stem cell derived pancreatic islet differentiationVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 3068US2020332262A1Re-aggregation of stem cell-derived pancreatic beta cellsSEMMA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3167US2025243464A1Enhanced differentiation of pancreatic islet cellsVERTEX PHARMA·Filed 2025·Application pending·0 cites
- 3266US2025057880A1Cell therapy for diabetesVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 3364US2021198632A1Methods of enhancing stem cell differentiation into beta cellsVERTEX PHARMA·Filed 2020·Application pending·0 cites
- 3461US2023332107A1Cell therapy for diabetesVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 3560US2022235327A1Pancreatic differentiationVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 3659US2024358767A1Stem cell differentiation and chemical compoundsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 3757US2024271100A1In vitro differentiation of pancreatic endocrine cellsVERTEX PHARMA·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when George Harb files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →